The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A retrospective study on the efficacy and safety of regorafenib or regorafenib combined with immune-checkpoint-inhibitors (ICIs) after first-line therapy in patients with advanced hepatocellular carcinoma.
 
Tao Yan
No Relationships to Disclose
 
Caiyun Peng
No Relationships to Disclose
 
Lingxiang Yu
No Relationships to Disclose
 
Xuezhang Duan
No Relationships to Disclose
 
Dong Ji
No Relationships to Disclose
 
Linzhi Zhang
No Relationships to Disclose
 
Jiamin Cheng
No Relationships to Disclose
 
Tong Wu
No Relationships to Disclose
 
Guodong Su
No Relationships to Disclose
 
Yi Jing
No Relationships to Disclose
 
Yinyin Li
No Relationships to Disclose
 
Yinying Lu
No Relationships to Disclose